Showing results (1-10 of 4,449) with videos related to
Sort By:
Pageof 445
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 6, 2025
Case report: tigecycline-induced procalcitonin elevationBenben Zhu, Ting Yang, Dongsheng WangNaunyn-Schmiedeberg'S Archives of Pharmacology|November 22, 2025
A case of levofloxacin injection-induced lower limb edemaTing Yang, Hairui Wang, Benben Zhu, et al.Frontiers in Pharmacology|April 24, 2026
Trilaciclib for prophylaxis of chemotherapy-induced myelosuppression in solid tumor patients: a systematic review and meta-analysisTing Yang, Pengjie Yang, Danyang Meng, et al.Frontiers in Oncology|October 13, 2025
Immunotherapy in the perioperative management of esophageal squamous cell carcinoma: recent developmentsMengfei Sun, Pengjie Yang, Ting Yang, et al.Journal of Thoracic Disease|January 12, 2026
Prognostic value of left gastric artery lymph node metastasis in patients with thoracic esophageal squamous cell carcinoma: a retrospective cohort studyPengjie Yang, Pubo Shi, Ting Yang, et al.Journal of Thoracic Disease|September 15, 2025
Efficacy and safety of postoperative adjuvant immunotherapy for esophageal cancer: a systematic review and meta-analysisJingjing Zhang, Pengjie Yang, Dehui Zhao, et al.Frontiers in Immunology|March 16, 2026
Efficacy and safety of neoadjuvant immunotherapy in locally advanced resectable esophageal squamous cell carcinoma: a network meta-analysis and real-world studyMengfei Sun, Pengjie Yang, Ling Qi, et al.Journal of Thoracic Disease|April 16, 2026
Prognostic impact of treatment modalities and examined lymph nodes count on survival in T3-4 esophageal cancer: a retrospective cohort and predictive modeling study from the Surveillance, Epidemiology, and End Results databaseYu Wu, Pubo Shi, Pengjie Yang, et al.Journal of Thoracic Disease|June 18, 2025
Development and validation of a prognostic model for overall survival in pN0 esophageal cancer patients after neoadjuvant chemotherapy: a SEER database-based studyPengjie Yang, Ting Yang, Tianlai Liu, et al.Naunyn-Schmiedeberg'S Archives of Pharmacology|May 25, 2026
Case report: Delayed onset rash, delirium, and cross allergic reactions caused by sequential administration of cefoperazone sulbactam, meropenem, and piperacillin tazobactamJingjing Zhang, Kang Gao, Huijie Jiao, et al.Pageof 445